Mark W. Schwartz
2013
In 2013, Mark W. Schwartz earned a total compensation of $1.6M as President & Chief Executive Officer at Galena Biopharma.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Option Awards | $1,093,640 |
| Salary | $365,000 |
| Other | $693 |
| Total | $1,584,333 |
Schwartz received $1.1M in option awards, accounting for 69% of the total pay in 2013.
Schwartz also received $125K in bonus, $365K in salary and $693 in other compensation.
Rankings
In 2013, Mark W. Schwartz's compensation ranked 4,725th out of 12,286 executives tracked by ExecPay. In other words, Schwartz earned more than 61.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,725 out of 12,286 | 62nd |
Division Manufacturing | 1,622 out of 4,612 | 65th |
Major group Chemicals And Allied Products | 469 out of 1,462 | 68th |
Industry group Drugs | 329 out of 1,156 | 72nd |
Industry Pharmaceutical Preparations | 263 out of 890 | 70th |
Source: SEC filing on June 3, 2016.
Schwartz's colleagues
We found one more compensation record of an executive who worked with Mark W. Schwartz at Galena Biopharma in 2013.
2013
Ryan Dunlap
Galena Biopharma